Bruker Quarterly Income Statement
NASDAQ: BRKRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bruker revenue and earnings
In the quarter ended Jun 30, 2026, Bruker generated $838.5 million in revenue, up 5.2% from the same quarter a year earlier. Bruker reported a net loss of $52.0 million, compared with net income of $7.6 million a year earlier. Gross margin was 49.6% (up from 44.9%) and operating margin -7.8%.
Diluted earnings per share came in at -$0.41, down from $0.05.
Summary generated from market data by MetaCap's automated system. Methodology
Bruker income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 838.50M | 823.40M | 977.20M | 860.50M | 797.40M | 801.40M | 979.60M | 864.40M | 800.70M | 721.70M | 854.50M | 742.80M |
| Revenue growth (YoY) | +5.15% | +2.75% | -0.24% | -0.45% | -0.41% | +11.04% | +14.64% | +16.37% | +17.42% | +5.31% | +20.62% | +16.26% |
| Cost of Revenue | 422.50M | 443.60M | 528.00M | 481.10M | 439.50M | 410.20M | 486.30M | 445.60M | 416.10M | 368.90M | 424.20M | 360.00M |
| Gross Profit | 416.00M | 379.80M | 449.20M | 379.40M | 357.90M | 391.20M | 493.30M | 418.80M | 384.60M | 352.80M | 430.30M | 382.80M |
| Operating Expenses | 481.30M | 369.60M | 372.90M | 431.20M | 346.00M | 359.40M | 421.20M | 350.70M | 336.50M | 288.00M | 326.80M | 258.30M |
| Research & Development | 94.30M | 101.30M | 99.60M | 98.30M | 100.20M | 97.10M | 104.40M | 98.10M | 92.20M | 81.80M | 83.50M | 71.30M |
| Selling, General & Admin | 238.90M | 242.10M | 247.20M | 242.50M | 231.40M | 225.40M | 247.30M | 229.90M | 221.30M | 195.30M | 211.20M | 177.60M |
| Operating Income | -65.30M | 10.20M | 76.30M | -51.80M | 11.90M | 31.80M | 72.10M | 68.10M | 48.10M | 64.80M | 103.50M | 124.50M |
| Interest Expense | 17.80M | 12.20M | 11.20M | 20.30M | 15.70M | 13.10M | 15.60M | 11.60M | 15.70M | 5.00M | 4.40M | 3.90M |
| Other Income (Expense) | 24.60M | 11.70M | -8.10M | -20.00M | -11.40M | -6.70M | -16.00M | -12.80M | -24.20M | 6.80M | 137.40M | -5.30M |
| Pretax Income | -40.70M | 21.90M | 68.20M | -71.80M | 500.00K | 25.10M | 56.10M | 55.30M | 23.90M | 71.60M | 240.90M | 119.20M |
| Income Tax | 14.20M | 2.50M | 37.80M | -14.10M | -3.10M | 8.70M | 40.70M | 14.80M | 16.10M | 19.80M | 37.10M | 30.80M |
| Net Income | -52.00M | 14.40M | 26.00M | -59.60M | 7.60M | 17.40M | 13.70M | 40.90M | 7.60M | 50.90M | 205.50M | 88.10M |
| Net Income growth (YoY) | -784.21% | -17.24% | +89.78% | -245.72% | 0.00% | -65.82% | -93.33% | -53.58% | -86.69% | -33.46% | +110.99% | 0.00% |
| EPS (Basic) | -0.41 | 0.02 | 0.10 | -0.41 | 0.05 | 0.11 | 0.09 | 0.27 | 0.05 | 0.35 | 1.41 | 0.60 |
| EPS (Diluted) | -0.41 | 0.02 | 0.10 | -0.41 | 0.05 | 0.11 | 0.09 | 0.27 | 0.05 | 0.35 | 1.39 | 0.60 |
| Shares Outstanding (Basic) | 152.30M | 152.20M | — | 151.80M | 151.60M | 151.60M | — | 151.50M | 147.40M | 145.20 | — | 146.60 |
| Shares Outstanding (Diluted) | 152.30M | 152.70M | — | 151.80M | 151.70M | 151.90M | — | 152.00M | 148.00M | 145.90 | — | 147.30 |
| EBITDA | -7.30M | 68.50M | 134.40M | 3.90M | 68.00M | 82.20M | 125.00M | 119.10M | 93.20M | 99.50M | 140.80M | 151.10M |
| Gross Margin | 49.61% | 46.13% | 45.97% | 44.09% | 44.88% | 48.81% | 50.36% | 48.45% | 48.03% | 48.88% | 50.36% | 51.53% |
| Operating Margin | -7.79% | 124.00% | 7.81% | -6.02% | 149.00% | 3.97% | 7.36% | 7.88% | 6.01% | 8.98% | 12.11% | 16.76% |
| Net Margin | -6.20% | 1.75% | 2.66% | -6.93% | 95.00% | 2.17% | 140.00% | 4.73% | 95.00% | 7.05% | 24.05% | 11.86% |
This table shows 12 quarterly periods of Bruker's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow BRKR's reporting calendar. What is a income statement?